BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28369758)

  • 21. Constitutional mismatch repair deficiency presenting in childhood as three simultaneous malignancies.
    Walter AW; Ennis S; Best H; Vaughn CP; Swensen JJ; Openshaw A; Gripp KW
    Pediatr Blood Cancer; 2013 Nov; 60(11):E135-6. PubMed ID: 23729388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy.
    Suerink M; Ripperger T; Messiaen L; Menko FH; Bourdeaut F; Colas C; Jongmans M; Goldberg Y; Nielsen M; Muleris M; van Kouwen M; Slavc I; Kratz C; Vasen HF; Brugiѐres L; Legius E; Wimmer K
    J Med Genet; 2019 Feb; 56(2):53-62. PubMed ID: 30415209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Durno C; Boland CR; Cohen S; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ; Rex DK
    Am J Gastroenterol; 2017 May; 112(5):682-690. PubMed ID: 28349994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.
    Ponti G; Manfredini M; Tomasi A; Pellacani G
    Gene; 2016 Sep; 589(2):127-32. PubMed ID: 26143115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilomatricomas and café au lait macules as herald signs of constitutional mismatch repair deficiency (CMMRD) syndrome-A case report.
    Gupta A; George R; Aboobacker FN; ThamaraiSelvi B; Priscilla AJ
    Pediatr Dermatol; 2020 Nov; 37(6):1139-1141. PubMed ID: 32876971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report of endometrial cancer with a microcytic, elongated, and fragmented pattern of invasion and DNA mismatch repair deficiency.
    Sookram J; Barroeta JE; Aikins JK
    Int J Gynaecol Obstet; 2018 May; 141(2):252-254. PubMed ID: 29369342
    [No Abstract]   [Full Text] [Related]  

  • 27. Turcot syndrome: a case report in an unsuspected setting.
    Chung HJ; Oh ST; Kim JG; Kang WK
    J Gastrointest Surg; 2012 Feb; 16(2):411-4. PubMed ID: 21959784
    [No Abstract]   [Full Text] [Related]  

  • 28. Recommendations on Surveillance and Management of Biallelic Mismatch Repair Deficiency (BMMRD) Syndrome: A Consensus Statement by the US Multi-society Task Force on Colorectal Cancer.
    Durno C; Boland CR; Cohen S; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ; Rex DK
    J Pediatr Gastroenterol Nutr; 2017 May; 64(5):836-843. PubMed ID: 28353469
    [No Abstract]   [Full Text] [Related]  

  • 29. Muir-Torre Syndrome / Turcot Syndrome overlap? A patient with sebaceous carcinoma, colon cancer, and a malignant astrocytoma.
    Kleinerman R; Marino J; Loucas E
    Dermatol Online J; 2012 May; 18(5):3. PubMed ID: 22630573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer.
    Bush L; Aronson M; Tabori U; Campbell BB; Bedgood RB; Jasperson K
    Fam Cancer; 2019 Jan; 18(1):105-108. PubMed ID: 29785566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
    Lusis EA; Travers S; Jost SC; Perry A
    Neurosurgery; 2010 Sep; 67(3):811-7; discussion 817. PubMed ID: 20657316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group.
    Aronson M; Colas C; Shuen A; Hampel H; Foulkes WD; Baris Feldman H; Goldberg Y; Muleris M; Wolfe Schneider K; McGee RB; Jasperson K; Rangaswami A; Brugieres L; Tabori U
    J Med Genet; 2022 Apr; 59(4):318-327. PubMed ID: 33622763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late-Onset Biallelic Mismatch Repair Deficiency Syndrome.
    Ebner DW; Al-Bawardy B; Sweetser S
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):e31-e32. PubMed ID: 28602968
    [No Abstract]   [Full Text] [Related]  

  • 34. Copy number variations as potential diagnostic and prognostic markers for CNS melanocytic neoplasms in neurocutaneous melanosis.
    van Engen-van Grunsven AC; Rabold K; Küsters-Vandevelde HV; Rijntjes J; Djafarihamedani M; Hehir-Kwa JY; Küsters B; Willemsen MA; van der Burgt I; Wesseling P; Blokx WA; Groenen PJ
    Acta Neuropathol; 2017 Feb; 133(2):333-335. PubMed ID: 27988846
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres.
    Grant M; Haydon A; Au L; Wilkins S; Oliva K; Segelov E; Antill Y; Carne P; Ranchod P; Polglase A; Farmer C; Chin M; Wale R; Simpson P; Bell S; Skinner S; McMurrick P; Shapiro J
    Int J Surg; 2018 Mar; 51():71-75. PubMed ID: 29367039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple pilomatricomas with somatic CTNNB1 mutations in children with constitutive mismatch repair deficiency.
    Chmara M; Wernstedt A; Wasag B; Peeters H; Renard M; Beert E; Brems H; Giner T; Bieber I; Hamm H; Sciot R; Wimmer K; Legius E
    Genes Chromosomes Cancer; 2013 Jul; 52(7):656-64. PubMed ID: 23629955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pitfalls in molecular analysis for mismatch repair deficiency in a family with biallelic pms2 germline mutations.
    Leenen CH; Geurts-Giele WR; Dubbink HJ; Reddingius R; van den Ouweland AM; Tops CM; van de Klift HM; Kuipers EJ; van Leerdam ME; Dinjens WN; Wagner A
    Clin Genet; 2011 Dec; 80(6):558-65. PubMed ID: 21204794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of constitutional mismatch repair deficiency in children and adolescents with acute lymphoblastic leukemia.
    Gallon R; Phelps R; Betts L; Hayes C; Masic D; Irving JAE; McAnulty C; Saha V; Vora A; Wimmer K; Motwani J; Macartney C; Burn J; Jackson MS; Moorman AV; Santibanez-Koref M
    Leuk Lymphoma; 2023 Jan; 64(1):217-220. PubMed ID: 36272172
    [No Abstract]   [Full Text] [Related]  

  • 39. Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohorts.
    Buchanan DD; Clendenning M; Rosty C; Eriksen SV; Walsh MD; Walters RJ; Thibodeau SN; Stewart J; Preston S; Win AK; Flander L; Ouakrim DA; Macrae FA; Boussioutas A; Winship IM; Giles GG; Hopper JL; Southey MC; English D; Jenkins MA
    J Gastroenterol Hepatol; 2017 Feb; 32(2):427-438. PubMed ID: 27273229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PMS2 inactivation by a complex rearrangement involving an HERV retroelement and the inverted 100-kb duplicon on 7p22.1.
    Vogt J; Wernstedt A; Ripperger T; Pabst B; Zschocke J; Kratz C; Wimmer K
    Eur J Hum Genet; 2016 Nov; 24(11):1598-1604. PubMed ID: 27329736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.